))
Pioneering Personalized Allergy Relief with Shani Bocian
Manage episode 387507974 series 2546725
コンテンツは Mike Biselli によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Mike Biselli またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
This episode’s Community Champion Sponsor is Catalyst. To virtually tour Catalyst and claim your space on campus, or host an upcoming event: CLICK HERE
---
Episode Overview:
During this episode, we spend time with Shani Bocian, founder and CEO of Allermi, an innovative telehealth startup aiming to improve the lives of allergy sufferers through personalized prescription nasal sprays.
Born from Shani’s mission to enhance the health of others and her father’s 30 years of allergy research at Stanford University, Allermi provides customized relief by combining medications to target individual symptoms.
While together, Shani explains how Allermi’s approach helps chronic allergy patients who struggled with over-the-counter options and brings specialized care to those unable to access in-person allergists. We also explore Allermi’s rocketship growth, serving thousands of customers in just one year, and how Shani is taking the company to the next level.
With an unrelenting focus on patients’ allergy health, Shani and Allermi team are pioneering much-needed innovation in a $15 billion industry. Join us as she shares her vision for leading change in allergy care nationwide. Let’s go!
Episode Highlights:
- Origins: Allermi was born from Shani's father, Dr. Robert Bocian's 30 years of allergy research and "potions" at Stanford to provide better relief
- Customized Care: Personalized multi-ingredient nasal sprays target individual symptoms vs one-size-fits-all over-the-counter options
- Telehealth Innovation: On-demand virtual allergist appointments increase access and care nationwide
- Rocketship Growth: Served over 15,000 customers in just the first year since launching
- Funding The Future: Recently closed a $7.5 million seed round to fuel further expansion
About our Guest:
Shani Bocian is the visionary founder and CEO of Allermi, a groundbreaking telehealth startup based in San Francisco that aims to improve the lives of chronic and seasonal allergy sufferers with personalized prescription nasal sprays. Founded in 2021, Allermi has quickly garnered attention and funding for its innovative approach to combating allergy symptoms.
Born and raised in Palo Alto, California, Shani’s family has a background in the medical field and her father, Robert Bocian, MD, PhD, FAAAAI, is a Professor of Allergy-Immunology at Stanford University. Her father’s expertise and passion for helping patients with rhinitis and hay fever served as the catalyst for Allermi’s creation.
With Shani’s mission to help people improve their health and her father’s decades of clinical experience, Allermi became a family endeavor. They assembled a team of dedicated professionals, including six full-time employees on the operational side and approximately 20 licensed physicians providing telehealth services across all 50 states.
Links Supporting This Episode:
- Allermi Website: CLICK HERE
- Shani Bocian LinkedIn page: CLICK HERE
- Allermi Twitter page: CLICK HERE
- Mike Biselli LinkedIn page: CLICK HERE
- Mike Biselli Twitter page: CLICK HERE
- Visit our website: CLICK HERE
- Subscribe to newsletter: CLICK HERE
- Guest nomination form: CLICK HERE
299 つのエピソード
シェア
